AstraZeneca Annual Report and Financial Statements Form 20-F Information 2004 123 34 Called-up share capital of parent company Allotted, called-up Authorised and fully paid 2004 2004 2003 $m $m $m Ordinary Shares $0.25 each 411 411 423 Unissued Ordinary Shares $0.25 each 189 Redeemable Preference Shares 1 each 50,000 600 411 423 The Redeemable Preference Shares carry limited class voting rights and no dividend rights.
This class of shares is capable of redemption at par at the option of the Company on the giving of seven days written notice to the registered holder of the shares.
The movements in share capital during the year can be summarised as follows: No.
of shares million $m At beginning of year 1,693 423 Issues of shares 21 Re-purchase of shares 50 13 At 31 December 2004 1,645 411 Share re-purchase During the year the Company re-purchased, and subsequently cancelled, 50,100,000 Ordinary Shares at an average price of 2376 pence per share.
The total consideration, including expenses, was $2,212m.
The excess of the consideration over the nominal value has been charged against the profit and loss account reserve.
Share schemes A total of 2,456,945 Ordinary Shares were issued during the year in respect of share schemes.
Details of movements in the number of Ordinary Shares under option are shown in Note 29: details of options granted to Directors are shown in the Directors Remuneration Report.
